A Two-part, Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Fenebrutinib (Part A) and the Effect of Fenebrutinib on the QT/QTc Interval in Healthy Participants (Part B)

Authors
Category Primary study
JournalNeurology
Year 2024
This article has no abstract
Epistemonikos ID: 5245da6d0b5a53ac2af5e829ef6fbc457f15b4c5
First added on: Feb 19, 2025